Literature DB >> 1984573

Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp.

S R Myers1, M P Diamond, B A Adkins-Marshall, P E Williams, R Stinsen, A D Cherrington.   

Abstract

The aim of this study was to examine the influence of small changes in glucagon on hepatic glucose production during a euglycemic, hyperinsulinemic clamp. During 1.0 mU/kg.min insulin infusion, euglycemia was maintained by glucose infusion and glucagon was infused at various rates so as to cause plasma glucagon levels to increase, decrease, or remain unchanged. Changes in glucagon were found to be positively associated with changes in glucose production and inversely related to the degree of suppression of tracer or arteriovenous difference determined endogenous glucose production. Thus, animals in which the glucagon levels increased, appeared to have decreased hepatic insulin sensitivity, while animals in which glucagon levels decreased, appeared to have increased insulin sensitivity. In conclusion, since glucagon often declines during a euglycemic hyperinsulinemic clamp, and since small changes in glucagon can have marked effects on the suppression of hepatic glucose output even in the presence of high insulin levels, changes in glucagon should be considered when conclusions regarding hepatic insulin sensitivity are being drawn.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984573     DOI: 10.1016/0026-0495(91)90194-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCalpha and PKCdelta.

Authors:  Y Z De Marinis; E Zhang; S Amisten; J Taneera; E Renström; P Rorsman; L Eliasson
Journal:  Diabetologia       Date:  2009-12-18       Impact factor: 10.122

Review 2.  Physiologic action of glucagon on liver glucose metabolism.

Authors:  C J Ramnanan; D S Edgerton; G Kraft; A D Cherrington
Journal:  Diabetes Obes Metab       Date:  2011-10       Impact factor: 6.577

Review 3.  Unraveling the Regulation of Hepatic Metabolism by Insulin.

Authors:  Paul M Titchenell; Mitchell A Lazar; Morris J Birnbaum
Journal:  Trends Endocrinol Metab       Date:  2017-04-14       Impact factor: 12.015

4.  Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.

Authors:  Robert A Rizza
Journal:  Diabetes       Date:  2010-08-12       Impact factor: 9.461

5.  Idiopathic reactive hypoglycemia: a role for glucagon?

Authors:  F Leonetti; L Morviducci; A Giaccari; P Sbraccia; S Caiola; D Zorretta; O Lostia; G Tamburrano
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

6.  Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.

Authors:  A Giacca; S J Fisher; Z Q Shi; R Gupta; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

7.  Short-term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability.

Authors:  P J Flakoll; L S Wentzel; D E Rice; J O Hill; N N Abumrad
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

8.  Histological Changes on Liver Glycogen Storage in Mice (Mus musculus) Caused by Unbalanced Diets.

Authors:  Esma Ulusoy; Banu Eren
Journal:  Clin Med Pathol       Date:  2008-04-23

9.  Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.

Authors:  Paul M Titchenell; Qingwei Chu; Bobby R Monks; Morris J Birnbaum
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 14.919

10.  Intra-islet glucagon secretion and action in the regulation of glucose homeostasis.

Authors:  Qinghua Wang; Xinyun Liang; Susanne Wang
Journal:  Front Physiol       Date:  2013-01-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.